Sorting the Future of Intelligent Cell Biology

Next Generation AI-driven Cell Sorting and Analysis Platforms for Key Biotech Sector

Cell Therapy → Bio-Production → Living Cell Analysis & Validation

Active partnerships across HK, US, UK & EU

Uniquely Merging

AI and Biotechnology

Key Partners

Parent company: IND/ODD pathway for world’s first iPSC-derived kidney cell therapy

(NMPA + FDA ODD).

‍Strategic Academic Partner: ITF/RIF grants

‍Industrial Partner for Synthetic Bio Projects

Meet our Next-Gen Solutions Suite for Biotechnology

And how we are advancing the frontiers of cell therapy and regenerative medicine , along with other key sectors of Biotech.

Learn more about us